Different subtypes of EGFR mutations in primary NSCLC patients were evaluated (Figure 1C), and more EGFR mutations were found in adenocarcinoma than in squamous cell carcinoma and large cell carcinoma (Figure 1D), and. Here, EGFR is linked to large cell carcinoma.